Abstract
Eradication of Gram-positive biofilms is a critical aspect in implant-associated infection treatment. Although antibiotic-containing particulate carriers may be a promising strategy for overcoming biofilm tolerance, the assessment of their interaction with biofilms has not been fully explored. In the present work, the antibiofilm activity of daptomycin- and vancomycin-loaded poly(methyl methacrylate) (PMMA) and PMMA-Eudragit RL 100 (EUD) microparticles against methicillin-resistant Staphylococcus aureus (MRSA) and polysaccharide intercellular adhesin-positive S. epidermidis biofilms was investigated using isothermal microcalorimetry (IMC) and fluorescence in situ hybridization (FISH). The minimal biofilm inhibitory concentrations (MBIC) of MRSA biofilms, as determined by IMC, were 5 and 20 mg/mL for daptomycin- and vancomycin-loaded PMMA microparticles, respectively. S. epidermidis biofilms were less susceptible, with a MBIC of 20 mg/mL for daptomycin-loaded PMMA microparticles. Vancomycin-loaded microparticles were ineffective. Adding EUD to the formulation caused a 4- and 16-fold reduction of the MBIC values of daptomycin-loaded microparticles for S. aureus and S. epidermidis, respectively. FISH corroborated the IMC results and provided additional insights on the antibiofilm effect of these particles. According to microscopic analysis, only daptomycin-loaded PMMA-EUD microparticles were causing a pronounced reduction in biofilm mass for both strains. Taken together, although IMC indicated that a biofilm inhibition was achieved, microscopy showed that the biofilm was not eradicated and still contained FISH-positive, presumably viable bacteria, thus indicating that combining the two techniques is essential to fully assess the effect of microparticles on staphylococcal biofilms.
Similar content being viewed by others
References
Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–54.
Høiby N, Bjarnsholt T, Moser C, Bassi GL, Coenye T, Donelli G, et al. ESCMID guideline for the diagnosis and treatment of biofilm infections. Clin Microbiol Infect. 2015;21(Suppl 1):S1–25.
Santos Ferreira I, Bettencourt A, Almeida AJ. Nanoparticulate platforms for targeting bone infections: meeting a major therapeutic challenge. Nanomed (Lond). 2015;10:3147–66.
Forier K, Raemdonck K, De Smedt SC, Demeester J, Coenye T, Braeckmans K. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J Control Release. 2014;190C:607–23.
Steenbergen JN, Alder J, Thorne GM, Tally FP. Daptomycin: a lipopeptide antibiotic for the treatment of serious gram-positive infections. J Antimicrob Chemother. 2005;55:283–8.
Mihailescu R, Tafin UF, Corvec S, Oliva A, Betrisey B, Borens O, et al. High activity of fosfomycin and rifampin against methicillin-resistant Staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother. 2014;58:2547–53.
Ferreira IS, Bettencourt A, Bétrisey B, Gonçalves LM, Trampuz A, Almeida AJ. Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry. Int J Pharm. 2015;485:171–82.
Lewis G, Daniels AU. Use of isothermal heat-conduction microcalorimetry (IHCMC) for the evaluation of synthetic biomaterials. J Biomed Mater Res B Appl Biomater. 2003;66:487–501.
Braissant O, Wirz D, Gopfert B, Daniels AU. Use of isothermal microcalorimetry to monitor microbial activities. FEMS Microbiol Lett. 2010;303:1–8.
Von AU, Wirz D, Daniels AU. Isothermal microcalorimetry—a new method for MIC determinations: results for 12 antibiotics and reference strains of E. coli and S. aureus. BMC Microbiol. 2009;9:106. https://doi.org/10.1186/1471-2180-9-106.
Santos Ferreira I, Bettencourt AF, Gonçalves LM, Kasper S, Bétrisey B, Kikhney J, et al. Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms. Int J Nanomed. 2015;10:4351–66.
Moter A, Göbel U. Fluorescence in situ hybridization (FISH) for direct visualization of microorganisms. J Microbiol Methods. 2000;41:85–112.
Hall-Stoodley L, Stoodley P, Kathju S, Høiby N, Moser C, Costerton JW, et al. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol. 2012;65:127–45.
Schillinger C, Petrich A, Lux R, Riep B, Kikhney J, Friedmann A, et al. Co-localized or randomly distributed? Pair cross correlation of in vivo grown subgingival biofilm bacteria quantified by digital image analysis. PLoS One. 2012;7:e37583. https://doi.org/10.1371/journal.pone.0037583.
Stewart PS, Franklin MJ. Physiological heterogeneity in biofilms. Nat Rev Microbiol. 2008;6:199–210.
Poulsen LK, Ballard G, Stahl DA. Use of rRNA fluorescence in situ hybridization for measuring the activity of single cells in young and established biofilms. Appl Environ Microbiol. 1993;59:1354–60.
DeLong E, Wickham G, Pace N. Phylogenetic stains: ribosomal RNA-based probes for the identification of single cells. Science. 1989;243:1360–3.
European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2014. Antimicrobial wild type distributions of microorganisms—reference database. http://www.eucast.org/. Accessed 16 Aug 2017.
Mack D, Siemssen N, Laufs R. Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion. Infect Immun. 1992;60:2048–57.
Bettencourt A, Florindo HF, Ferreira IF, Matos A, Monteiro J, Neves C, et al. Incorporation of tocopherol acetate-containing microparticles in acrylic bone cement. J Microencapsul. 2010;27:533–41.
Clinical and Laboratory Standards Institute. Methods for determining bactericidal activity of antimicrobial agents; approved guideline M26-A. Wayne, PA, USA: CLSI; 1999.
Amann RI, Blinder BJ, Olson RJ, Chisholm SW, Devereux R, Stahl DA. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol. 1990;56:1919–25.
Trebesius K, Leitritz L, Adler K, Schubert S, Autenrieth IB, Heesemann J. Culture independent and rapid identification of bacterial pathogens in necrotising fasciitis and streptococcal toxic shock syndrome by fluorescence in situ hybridisation. Med Microbiol Immunol. 2000;188:169–75.
Dillen K, Vandervoort J, Van den Mooter G, Ludwig A. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Int J Pharm. 2006;314:72–82.
Takács-Novák K, Noszál B, Tokes-Kovesdi M, Szasz G. Acid base properties and proton-speciation of vancomycin. Int J Pharm. 1993;89:261–3.
Hajdu S, Lassnigg A, Graniger W, Hirschl AM, Presterl E. Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. J Orthop Res. 2009;27:1361–5.
Leite B, Gomes F, Teixeira P, Souza C, Pizzolitto E, Oliveira R. In vitro activity of daptomycin, linezolid and rifampicin on Staphylococcus epidermidis biofilms. Curr Microbiol. 2011;63:313–7.
Claessens J, Roriz M, Merckx R, Baatsen P, Van Mellaert L, Van Eldere J. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro. Int J Antimicrob Agents. 2015;45:368–75.
Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35:322–32.
Renner LD, Weibel DB. Physicochemical regulation of biofilm formation. MRS Bull. 2011;36:347–55.
Kerkhof L, Ward BB. Comparison of nucleic acid hybridization and fluorometry for measurement of the relationship between RNA/DNA ratio and growth rate in a marine bacterium. Appl Environ Microbiol. 1993;59:1303–9.
van der Vliet GM, Schepers P, Schukkink RA, van Gemen B, Klatser PR. Assessment of mycobacterial viability by RNA amplification. Antimicrob Agents Chemother. 1994;38:1959–65.
Stewart PS, Zhang T, Xu R, Pitts B, Walters MC, Roe F, et al. Reaction–diffusion theory explains hypoxia and heterogeneous growth within microbial biofilms associated with chronic infections. NPJ Biofilms Microbiomes. 2016;2:16012. https://doi.org/10.1038/npjbiofilms.2016.12.
Acknowledgements
The authors acknowledge Novartis Pharma (Basel, Switzerland) for the gift of daptomycin. The paper is based upon work from COST action (TD1305, IPROMEDAI).
Funding
This work was supported by the Portuguese government (Fundação para a Ciência e a Tecnologia) and FEDER Grants SFRH/BD/69260/2010, research projects proj. 6818 FCT/DAAD and EXCL/CTM-NAN/0166/2012 and strategic project iMed.ULisboa (UID/DTP/04138/2013).
Author information
Authors and Affiliations
Corresponding authors
Electronic Supplementary Material
ESM 1
(DOCX 786 kb).
Rights and permissions
About this article
Cite this article
Santos Ferreira, I., Kikhney, J., Kursawe, L. et al. Encapsulation in Polymeric Microparticles Improves Daptomycin Activity Against Mature Staphylococci Biofilms—a Thermal and Imaging Study. AAPS PharmSciTech 19, 1625–1636 (2018). https://doi.org/10.1208/s12249-018-0974-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-018-0974-7